{
    "2018-09-07": [
        [
            {
                "time": "2018-09-10",
                "original_text": "Daily Dividend Report: AMT, RCL, ABBV, AMAT, NUE, KRC",
                "features": {
                    "keywords": [
                        "Dividend",
                        "AMT",
                        "RCL",
                        "ABBV",
                        "AMAT",
                        "NUE",
                        "KRC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, ABBV and FB",
                "features": {
                    "keywords": [
                        "Class Actions",
                        "ACAD",
                        "ABBV",
                        "FB"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Vertex Completes Enrollment in Triple Combination Studies",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Triple Combination",
                        "Studies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "AbbVie Declares Quarterly Dividend",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Quarterly Dividend"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Lilly, Teva, Pfizer & Others Await FDA Decisions in September",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Teva",
                        "Pfizer",
                        "FDA Decisions"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Jim Cramer Weighs In On CarMax, AbbVie And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "CarMax",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}